<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="162603">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00981682</url>
  </required_header>
  <id_info>
    <org_study_id>SPC-SER120-OL1-200903</org_study_id>
    <nct_id>NCT00981682</nct_id>
  </id_info>
  <brief_title>Long Term Safety Assessment of SER120 in Patients With Nocturia</brief_title>
  <official_title>A Phase III Open-Label Extension Study to Investigate the Safety of SER120 Nasal Spray Formulations in Patients With Nocturia Completing Study SPC-SER120-DB1-200901 or Study SPC-SER120-DB2-200902</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Serenity Pharmaceuticals, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Serenity Pharmaceuticals, Inc.</source>
  <brief_summary>
    <textblock>
      The hypothesis of this study is that SER120 is safe and well tolerated for use in nocturic
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>safety evaluation of SER120 in terms of laboratory and clinical assessments</measure>
    <time_frame>11 month study</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">376</enrollment>
  <condition>Nocturia</condition>
  <arm_group>
    <arm_group_label>SER120 (desmopressin)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SER120</intervention_name>
    <description>once a day treatment of nocturia</description>
    <arm_group_label>SER120 (desmopressin)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients completed SPC-SER120-DB1-200901 and SPC-SER120-DB2-200902 studies

          -  Willing to provide consent for the study

        Exclusion Criteria:

          -  Incontinence

          -  Diabetes Insipidus, Diabetes Mellitus

          -  CHF

          -  Renal Insufficiency

          -  Significant medical history which make participation unacceptable
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Stephen M. Auerbach, MD</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92660</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 27, 2014</lastchanged_date>
  <firstreceived_date>September 18, 2009</firstreceived_date>
  <firstreceived_results_disposition_date>December 19, 2013</firstreceived_results_disposition_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>decrease in the number of nocturic episodes for patients with nocturia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nocturia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted -->
</clinical_study>
